Starting a Fentanyl Test Strip Program from Scratch

Before launching distribution, confirm that your program structure aligns with the requirements of your funding sources. CDC OD2A, SAMHSA SOR/SOS, and state-level grants each have specific reporting obligations, allowable cost categories, and procurement procedures. Establish your compliance framework early — it is far easier to build data collection into your launch than to retrofit it later. Subcheck provides grant-specific guidance and pre-formatted compliance templates to streamline this process.

Not all fentanyl test strips perform equally. A 2023 study in Harm Reduction Journal tested two major brands against 251 synthetic opioids and found significant detection blind spots: 50 compounds were undetectable by either brand, and 80 were detectable by one brand but not the other. When evaluating suppliers, prioritize the following criteria. First, sensitivity and specificity: standard commercial strips typically detect fentanyl at a cutoff of 200 ng/mL for liquid and powder samples. Johns Hopkins Bloomberg School of Public Health found that immunoassay strips had the lowest detection limit and highest accuracy among tested methods.

Your distribution model should reflect your community\\

Robust data collection serves two purposes: it demonstrates program impact to funders and stakeholders, and it enables continuous quality improvement. At minimum, track distribution volume (strips distributed per site, per time period), distribution channel performance, and geographic reach. For outcome measurement, the research literature points to several validated approaches. Retrospective surveys, the most common method, ask PWUD about their FTS use and any behavior changes at follow-up visits.

Days 1-30 (Foundation): Finalize your funding sources and budget. Confirm grant compliance requirements with your funding agency. Place your initial supply order (a minimum of 2,000-5,000 strips is recommended for a meaningful pilot; at Subcheck\\

Insufficient training on result interpretation is the single most common operational failure. The faint line indicating a negative result is routinely misread as a positive, leading to inaccurate information being communicated to PWUD. Invest heavily in hands-on training with practice strips before your first distribution day. Distributing strips without ancillary supplies undermines usability.

Once your pilot is established and producing outcome data, scaling requires strategic expansion across channels, partnerships, and geography. The pharmacy channel represents one of the most promising growth vectors. Research published in 2025 identified seven implementation strategies for FTS provision in community pharmacies, with both pharmacists and harm reduction experts supporting the model. Pharmacies offer convenience, anonymity, and an existing healthcare touchpoint, though teams must determine whether strips will be sold over-the-counter or distributed free in partnership with public health agencies.

Subcheck is purpose-built for organizations launching or scaling FTS programs. Every new account receives a 30-day onboarding with a dedicated account manager who provides hands-on support through initial ordering, staff training resources, and standard operating procedure development. The SC-1 fentanyl test strip is priced at $0.20 per unit, bringing the cost of a 5,000-strip pilot order to just $1,000, well within the budget of most local health departments, community organizations, or grant-funded programs. For programs ready to address the evolving drug supply, the SC-X multi-panel strip is available at $0.85 per unit, providing broader detection coverage including xylazine.